Intelgenx Technologies Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 50

Employees

  • Latest Deal Type
  • M&A
  • (Announced)

  • Financing Rounds
  • 13

  • Investments
  • 1

Intelgenx Technologies General Information

Description

Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. The company focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer, and manufacturing scale-up, and commercial manufacturing. Its geographical segments are Europe, Canada, and the United States. The company generates the majority of its revenue from Europe.

Contact Information

Formerly Known As
Big Flash Corp
Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Corporate Office
  • 6420 Rue Abrams
  • Saint-Laurent, Quebec H4S 1Y2
  • Canada
+1 (514)
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Vertical(s)
Manufacturing, Life Sciences
Former Stock Listing
IGXT
Corporate Office
  • 6420 Rue Abrams
  • Saint-Laurent, Quebec H4S 1Y2
  • Canada
+1 (514)

Intelgenx Technologies Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Intelgenx Technologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturin
Drug Delivery
Saint-Laurent, Canada
50 As of 2023

London, United Kingdom
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Intelgenx Technologies Competitors (20)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vectura Group Formerly VC-backed London, United Kingdom
Oramed Pharmaceuticals Corporation New York, NY
Rani Therapeutics Formerly VC-backed San Jose, CA
Aquestive Therapeutics Formerly PE-Backed Warren, NJ
Par Pharmaceutical Companies Formerly PE-Backed Woodcliff Lake, NJ
You’re viewing 5 of 20 competitors. Get the full list »

Intelgenx Technologies Patents

  • 131

    Total Documents Applications and Grants

  • Total Patents Families

  • 49

    Granted

  • 36

    Pending

  • Expiring in next 12 mo

Intelgenx Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240139101-A1 Advanced oral film formulations Pending 01-Nov-2022
US-20230404937-A1 Novel disintegration oral film formulation with a controlled or sustained active release Pending 09-Jun-2022
US-20230225965-A1 Oral films with flavor entrapment Pending 19-Jan-2022
US-20220409584-A1 Stable tryptamine oral films Pending 16-Jun-2021
US-20240189331-A1 Novel tryptamine oral film formulation Pending 12-Feb-2021 A61K31/675
To view Intelgenx Technologies’s complete patent history, request access »

Intelgenx Technologies Board Members (9)

Name Representing Role Since
Self Board Member
McCarthy Tetrault Board Member
Self Founder
Self Board Member
ATAI Life Sciences Board Member
You’re viewing 5 of 9 board members. Get the full list »

Intelgenx Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Intelgenx Technologies Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Intelgenx Technologies‘s full profile, request access.

Request a free trial

Ready to get started?

Request a free trial

Intelgenx Technologies Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
Pillar5 Pharma 03-May-2010 Completed
To view Intelgenx Technologies’s complete exits history, request access »

Intelgenx Technologies FAQs

  • When was Intelgenx Technologies founded?

    Intelgenx Technologies was founded in 2003.

  • Where is Intelgenx Technologies headquartered?

    Intelgenx Technologies is headquartered in Saint-Laurent, Canada.

  • What is the size of Intelgenx Technologies?

    Intelgenx Technologies has 50 total employees.

  • What industry is Intelgenx Technologies in?

    Intelgenx Technologies’s primary industry is Drug Delivery.

  • Is Intelgenx Technologies a private or public company?

    Intelgenx Technologies is a Private company.

  • What is Intelgenx Technologies’s current revenue?

    The current revenue for Intelgenx Technologies is .

  • How much funding has Intelgenx Technologies raised over time?

    Intelgenx Technologies has raised $51.9M.

  • Who are Intelgenx Technologies’s investors?

    ATAI Life Sciences has invested in Intelgenx Technologies.

  • Who are Intelgenx Technologies’s competitors?

    Vectura Group, Oramed Pharmaceuticals, Rani Therapeutics, Aquestive Therapeutics, and Par Pharmaceutical Companies are some of the 20 competitors of Intelgenx Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »